News
News

News

08/16/2019 STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

HORSHAM, Pa. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
08/06/2019 STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates

STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates

Unaudited Second Quarter 2019 total revenue of $8.2 million increased 9% year-over-year First half total revenue of $15.6 million increased 12% year-over-year Recurring revenue of $6.0 million increased 16% year-over-year Domestic installed base increased from 754 to 764 sequentially Gross margin
07/08/2019 STRATA Skin Sciences Announces Direct Distribution Contract with Kosmo Meditech in Korea

STRATA Skin Sciences Announces Direct Distribution Contract with Kosmo Meditech in Korea

Company expanding globally and introducing recurring business model in Korea HORSHAM, Pa. , July 08, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing
06/11/2019 STRATA Skin Sciences to Present at Upcoming Investor Conferences

STRATA Skin Sciences to Present at Upcoming Investor Conferences

HORSHAM, Pa. , June 11, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,
05/17/2019 STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

HORSHAM, Pa. , May 17, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
04/05/2019 Strata Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

Strata Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

HORSHAM, Pa. , April 05, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
04/02/2019 STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full-Year 2018 Revenue Results

STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full-Year 2018 Revenue Results

Unaudited Fourth Quarter 2018 total revenue was $8.1 million, with recurring revenue of $6.0 million, representing a 10.7% increase in installed base utilization HORSHAM, Pa. , April 02, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical
03/05/2019 STRATA Skin Sciences to Participate in Oppenheimer’s 29th Annual Healthcare Conference

STRATA Skin Sciences to Participate in Oppenheimer’s 29th Annual Healthcare Conference

HORSHAM, Pa. , March 05, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced